相关实验视频

Updated: May 13, 2025

Right Ventricular Systolic Pressure Measurements in Combination with Harvest of Lung and Immune Tissue Samples in Mice

Right Ventricular Systolic Pressure Measurements in Combination with Harvest of Lung and Immune Tissue Samples in Mice

Published on: January 16, 2013

作为COPD和肺高血压之间的分子联系的RNA结合蛋白

Yi Liu¹, Ran Wang², Tao Jiang¹

¹Department of Respiratory and Critical Care Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu 322000, China.

International journal of medical sciences

|April 14, 2025

概括

肺高血压 (PH) 和慢性阻塞性肺病 (COPD) 分享涉及RNA结合蛋白 (RBPs) 的共同途径. 了解RBP为这些肺部疾病提供了新的生物标志物和治疗方法的潜力.

科学领域:

心血管和呼吸系统医学
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

肺高血压 (PH) 是一种导致右心力衰竭的血管疾病.
慢性阻塞性肺病 (COPD) 经常与PH同时发生,增加了患者的发病率和死亡率.
慢性肺炎的PH源于包括遗传,炎症和肺生理变化的因素.

研究的目的:

审查RNA结合蛋白 (RBPs) 在PH和COPD共享病原发生中的作用.
突出RBPs作为PH和COPD的潜在决定因素和生物标志物.
探索RBPs作为未来治疗干预的目标.

主要方法:

文献综述,重点关注PH和COPD中的RBPs.
分析涉及RBPs的转录后调节机制.
检查 erythropoietin 在调节肺微环境中的作用.

主要成果:

在调节基因表达,包括mRNA处理和翻译方面,RBP至关重要.
在PH和COPD中,红素会影响影响影响肺微环境的炎症媒介.
有证据表明,RBPs与这两种疾病的共同致病途径有关.

结论:

RBPs在PH和COPD相互关联的病理学中发挥着重要作用.
RBPs代表了疾病生物标志物的有希望的候选者.
向RBP可能为PH和COPD患者提供新的治疗策略.

关键词:

慢性慢性肺炎是一种慢性慢性肺炎,COPD是一种慢性肺炎.没有了,没有了,没有了.风险投资计划 (RBPs) 是一个.转录后的基因调节.肺血管重塑肺血管重塑肺血管阻力肺血管阻力

更多相关视频

Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension

Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension

Published on: February 11, 2017

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats

Published on: March 1, 2022

相关概念视频

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...